OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
Jeff Kamta, Maher Chaar, Anusha Ande, et al.
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 57
Jeff Kamta, Maher Chaar, Anusha Ande, et al.
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 57
Showing 1-25 of 57 citing articles:
Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles
Mehran Alavi, Mehrdad Hamidi
Drug Metabolism and Personalized Therapy (2019) Vol. 34, Iss. 1
Open Access | Times Cited: 332
Mehran Alavi, Mehrdad Hamidi
Drug Metabolism and Personalized Therapy (2019) Vol. 34, Iss. 1
Open Access | Times Cited: 332
Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
Mansour Sedighi, Abed Zahedi Bialvaei, Michael R. Hamblin, et al.
Cancer Medicine (2019) Vol. 8, Iss. 6, pp. 3167-3181
Open Access | Times Cited: 264
Mansour Sedighi, Abed Zahedi Bialvaei, Michael R. Hamblin, et al.
Cancer Medicine (2019) Vol. 8, Iss. 6, pp. 3167-3181
Open Access | Times Cited: 264
Antibody therapeutics and immunoregulation in cancer and autoimmune disease
Masahiro Yasunaga
Seminars in Cancer Biology (2019) Vol. 64, pp. 1-12
Open Access | Times Cited: 133
Masahiro Yasunaga
Seminars in Cancer Biology (2019) Vol. 64, pp. 1-12
Open Access | Times Cited: 133
Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine
Sara S. Bashraheel, Alexander Dömlingꝉ, Sayed K. Goda
Biomedicine & Pharmacotherapy (2020) Vol. 125, pp. 110009-110009
Open Access | Times Cited: 97
Sara S. Bashraheel, Alexander Dömlingꝉ, Sayed K. Goda
Biomedicine & Pharmacotherapy (2020) Vol. 125, pp. 110009-110009
Open Access | Times Cited: 97
IgE Antibodies: From Structure to Function and Clinical Translation
Brian J. Sutton, Anna M. Davies, Heather J. Bax, et al.
Antibodies (2019) Vol. 8, Iss. 1, pp. 19-19
Open Access | Times Cited: 87
Brian J. Sutton, Anna M. Davies, Heather J. Bax, et al.
Antibodies (2019) Vol. 8, Iss. 1, pp. 19-19
Open Access | Times Cited: 87
PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake
Jianye Zhang, Yanyan Yan, Jiajun Li, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 83
Jianye Zhang, Yanyan Yan, Jiajun Li, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 83
Synergistic Cancer Photochemotherapy via Layered Double Hydroxide-Based Trimodal Nanomedicine at Very Low Therapeutic Doses
Jianping Liu, Luyao Sun, Li Li, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 6, pp. 7115-7126
Closed Access | Times Cited: 72
Jianping Liu, Luyao Sun, Li Li, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 6, pp. 7115-7126
Closed Access | Times Cited: 72
Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment
Nour AlSawaftah, William G. Pitt, Ghaleb A. Husseini
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 3, pp. 1028-1049
Open Access | Times Cited: 58
Nour AlSawaftah, William G. Pitt, Ghaleb A. Husseini
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 3, pp. 1028-1049
Open Access | Times Cited: 58
B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling
Sadiye Amcaoglu Rieder, Jingya Wang, Natalie White, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 6, pp. 1503-1511
Open Access | Times Cited: 57
Sadiye Amcaoglu Rieder, Jingya Wang, Natalie White, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 6, pp. 1503-1511
Open Access | Times Cited: 57
Cancer immunotherapy: the art of targeting the tumor immune microenvironment
Jessé Lopes da Silva, Alexssandra Lima Siqueira dos Santos, Natalia Cristina Cardoso Nunes, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 2, pp. 227-240
Closed Access | Times Cited: 56
Jessé Lopes da Silva, Alexssandra Lima Siqueira dos Santos, Natalia Cristina Cardoso Nunes, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 2, pp. 227-240
Closed Access | Times Cited: 56
The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents
Y. Maurice Morillon, Ariana Sabzevari, Jeffrey Schlom, et al.
Anticancer Research (2020) Vol. 40, Iss. 10, pp. 5329-5341
Open Access | Times Cited: 50
Y. Maurice Morillon, Ariana Sabzevari, Jeffrey Schlom, et al.
Anticancer Research (2020) Vol. 40, Iss. 10, pp. 5329-5341
Open Access | Times Cited: 50
Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets
Carlos Cuesta‐Mateos, Ana Alcaraz‐Serna, Beatriz Somovilla-Crespo, et al.
Frontiers in Immunology (2018) Vol. 8
Open Access | Times Cited: 51
Carlos Cuesta‐Mateos, Ana Alcaraz‐Serna, Beatriz Somovilla-Crespo, et al.
Frontiers in Immunology (2018) Vol. 8
Open Access | Times Cited: 51
Recent Progress in European Advanced Therapy Medicinal Products and Beyond
Tracy T. L. Yu, Pravesh Gupta, Vincent Ronfard, et al.
Frontiers in Bioengineering and Biotechnology (2018) Vol. 6
Open Access | Times Cited: 50
Tracy T. L. Yu, Pravesh Gupta, Vincent Ronfard, et al.
Frontiers in Bioengineering and Biotechnology (2018) Vol. 6
Open Access | Times Cited: 50
Immunotherapy for pancreatic cancer: A long and hopeful journey
Jianwei Xu, Lei Wang, Yugang Cheng, et al.
Cancer Letters (2018) Vol. 425, pp. 143-151
Closed Access | Times Cited: 42
Jianwei Xu, Lei Wang, Yugang Cheng, et al.
Cancer Letters (2018) Vol. 425, pp. 143-151
Closed Access | Times Cited: 42
Tumor Treating Fields: At the Crossroads Between Physics and Biology for Cancer Treatment
Francesca A. Carrieri, Caleb Smack, Ismaeel Siddiqui, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 38
Francesca A. Carrieri, Caleb Smack, Ismaeel Siddiqui, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 38
Immuno-oncological Challenges and Chemoresistance in Veterinary Medicine: Probiotics as a New Strategic Tool
Muhammad Nisar, Tingdong Yan, Yi Cai, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Muhammad Nisar, Tingdong Yan, Yi Cai, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
The Role Of S100B Calcium-Binding Protein And Some Biochemical Markers In Early Detection And Progression Of Breast Cancer
Jamal A. ALJabbar Attawi, Sarah Y. Hailan, Mohammed Mohaibes
Research Square (Research Square) (2025)
Closed Access
Jamal A. ALJabbar Attawi, Sarah Y. Hailan, Mohammed Mohaibes
Research Square (Research Square) (2025)
Closed Access
Human health and snails
Varun Dhiman, Deepak Pant
Journal of Immunoassay and Immunochemistry (2020) Vol. 42, Iss. 3, pp. 211-235
Closed Access | Times Cited: 31
Varun Dhiman, Deepak Pant
Journal of Immunoassay and Immunochemistry (2020) Vol. 42, Iss. 3, pp. 211-235
Closed Access | Times Cited: 31
β-Glucans
Emma J. Murphy, Emanuele Rezoagli, Ian Major, et al.
Encyclopedia (2021) Vol. 1, Iss. 3, pp. 831-847
Open Access | Times Cited: 25
Emma J. Murphy, Emanuele Rezoagli, Ian Major, et al.
Encyclopedia (2021) Vol. 1, Iss. 3, pp. 831-847
Open Access | Times Cited: 25
Plant-Produced Monoclonal Antibody as Immunotherapy for Cancer
Meher Un Nessa, Md. Atiar Rahman, Yearul Kabir
BioMed Research International (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 26
Meher Un Nessa, Md. Atiar Rahman, Yearul Kabir
BioMed Research International (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 26
PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM)
Shuguang Zhang, Kun Chen, Huanmei Liu, et al.
Journal of Immunotherapy (2021) Vol. 44, Iss. 6, pp. 214-223
Open Access | Times Cited: 22
Shuguang Zhang, Kun Chen, Huanmei Liu, et al.
Journal of Immunotherapy (2021) Vol. 44, Iss. 6, pp. 214-223
Open Access | Times Cited: 22
Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions
Thomas Böldicke
Antibodies (2022) Vol. 11, Iss. 3, pp. 49-49
Open Access | Times Cited: 15
Thomas Böldicke
Antibodies (2022) Vol. 11, Iss. 3, pp. 49-49
Open Access | Times Cited: 15
Yanhong Wu, Hongying He, Kairong Zheng, et al.
Pigment Cell & Melanoma Research (2024) Vol. 37, Iss. 4, pp. 496-509
Closed Access | Times Cited: 2
Cancer as an ecomolecular disease and a neoplastic consortium
Santiago Ramón y Cajal, Claudia Capdevila, Javier Hernández‐Losa, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2017) Vol. 1868, Iss. 2, pp. 484-499
Closed Access | Times Cited: 20
Santiago Ramón y Cajal, Claudia Capdevila, Javier Hernández‐Losa, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2017) Vol. 1868, Iss. 2, pp. 484-499
Closed Access | Times Cited: 20
Immunoinformatics design of multiepitopes peptide-based universal cancer vaccine using matrix metalloproteinase-9 protein as a target
Abdelrahman H. Abdelmoneim, Mujahed I. Mustafa, Miyssa I. Abdelmageed, et al.
Immunological Medicine (2020) Vol. 44, Iss. 1, pp. 35-52
Open Access | Times Cited: 17
Abdelrahman H. Abdelmoneim, Mujahed I. Mustafa, Miyssa I. Abdelmageed, et al.
Immunological Medicine (2020) Vol. 44, Iss. 1, pp. 35-52
Open Access | Times Cited: 17
